Trial Profile
The effect on the renal functions and blood pressure of DPP-4 Inhibitor for the type 2 diabetic patients .
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- Acronyms STABAR
- 30 Mar 2011 New trial record